The PI3K/AKT/mTOR pathway, a critical oncogenic cascade, drives PCa progression by promoting tumor cell proliferation, migration, and therapeutic resistance through aberrant activation (Pungsrinont et al., 2021; Wylaź et al., 2023; Yi et al., 2023). Here, AKT1 is linked to posterior cortical atrophy.